(redirected from cholinesterase inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia.
Related to cholinesterase inhibitor: Donepezil, acetylcholine, Memantine
See: deterrent
References in periodicals archive ?
In fact, responses to intermittent stimulation in the study were as strong as those experienced by patients taking high doses of cholinesterase inhibitors, the scientists report.
In addition, this study suggested that cholinesterase inhibitors should be used in preference to Ginkgo biloba in patients with mild to moderate AD.
Galantamine is another cholinesterase inhibitor approved for patients with mild to moderate Alzheimer's disease, and it has dosing options of 6 mg, 8 mg, or 12 mg b.
Slowing the progression of Alzheimer's disease: The role of cholinesterase inhibitors.
Because NMDA antagonists work very differently from cholinesterase inhibitors, the two types of drugs can be prescribed in combination.
Developmental neurotoxicity of chlorpyrifos modeled in vitro, comparative effects of metabolites and other cholinesterase inhibitors on DNA synthesis in PC12 and C6 cells.
Cholinesterase inhibitor therapy should be started early and there is emerging data that efficacy extends to the late stages of the disease.
Cholinesterase inhibitors can have effects on the heart, including reports of hospital visits for syncope and bradycardia, for example.
Atri stresses that more data are needed, his study suggests that all people with moderate to severe AD should consider treatment with memantine and a cholinesterase inhibitor to maximize their functioning and slow the progression of Alzheimer's.
Oral cholinesterase inhibitor add-on therapy for cognitive enhancement in schizophrenia: a quantitative systematic review, part I.
AD Razadyne[R] (galantamine, formerly Cholinesterase inhibitor known as Reminyl[R]) prescribed to treat symptoms Prevents the breakdown of of mild to moderate AD acetylcholine and stimulates nicotinic receptors to release more acetylcholine in the brain.
A series of reports starting in 1991 confirmed that CPF is a cholinesterase inhibitor and that neonatal rats were more sensitive than adults when exposed to a single maximum tolerated dose (Pope and Chakraborti 1992; Pope et al.